PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
135 hedge funds and large institutions have $343M invested in Progenics Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 49 increasing their positions, 44 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
Holders
135
Holding in Top 10
–
Calls
$2.26M
Puts
$993K
Top Buyers
| 1 | +$18.7M | |
| 2 | +$9.13M | |
| 3 | +$8.01M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$959K |
| 5 |
Citigroup
New York
|
+$581K |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$4.24M | |
| 3 | -$4.01M | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$2.75M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.6M |